Sarcopenia in Menopausal Women: Current Perspectives

Area of Science:

• Gerontology
• Endocrinology
• Musculoskeletal Health

Background:

• Menopause triggers hormonal changes that may accelerate sarcopenia.
• Sarcopenia, characterized by muscle mass and strength loss, leads to functional impairment and disability.
• Preventing and treating sarcopenia is crucial for mitigating negative health outcomes in postmenopausal women.

Purpose of the Study:

• To present the prevalence of sarcopenia in postmenopausal women.
• To identify and discuss risk factors for sarcopenia in this demographic.
• To outline management strategies for sarcopenia in postmenopausal women.

Main Methods:

• This narrative review synthesizes existing literature on sarcopenia in postmenopausal women.
• Key areas of focus include prevalence, risk factors, and therapeutic interventions.
• Information was gathered through a comprehensive search of relevant scientific databases.

Main Results:

• Sarcopenia is a significant concern for postmenopausal women, impacting mobility and independence.
• Multiple factors contribute to sarcopenia risk in this population, including hormonal changes and lifestyle.
• Effective management involves lifestyle modifications and, when appropriate, hormone replacement therapy.

Conclusions:

• Sarcopenia poses a considerable health risk to postmenopausal women, necessitating proactive management.
• A multi-faceted approach combining diet, exercise, and potentially HRT is recommended.
• Further research into sarcopenia prevention and treatment in this group is warranted.